Bevacizumab in addition to standard of care did not shorten the time to improve hypoxemia in severe hypoxemic COVID-19 pneumonia in a prospective randomized controlled trial.Jacques Cadranel,Camille Rolland-Debord,Vincent Labbe,Sophie Tuffet,Benjamin Planquette,Jean-Louis Teboul,Romain Jouffroy,Bertrand Guidet,Guillaume Voiriot, Raphael Hindre, Laurent Saval,Julien Schmidt,Michael Darmon,Jonathan Marey,Armand Mekontso-Dessap,Camille Taille,Etienne Giroux-Leprieur, Florence Geny,Julien Mayaux,Guillaume Carteaux,Tabassome Simon,Antoine Parrot,Alexandra Rousseau,Muriel FartoukhEUROPEAN RESPIRATORY JOURNAL（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
